Caffeine inhalation effects on locomotor activity in mice

References

• Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002;40:1243–1255.
   PubMed Web of Science ®Google Scholar
• Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci. 2007;61:263–268.
   PubMed Web of Science ®Google Scholar
• Fredholm BB, Bättig K, Holmén J, Nehlig A, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999;51:83–133.
   PubMed Web of Science ®Google Scholar
• Daly JW, Fredholm BB. Caffeine–an atypical drug of dependence. Drug Alcohol Depend. 1998;51:199–206.
   PubMed Web of Science ®Google Scholar
• Malinauskas BM, Aeby VG, Overton RF, et al. A survey of energy drink consumption patterns among college students. Nutr J. 2007;6:35.
   PubMed Web of Science ®Google Scholar
• Coffin VL, Spealman RD. Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: comparison with caffeine and 7-(2-chloroethyl) theophylline. Eur J Pharmacol. 1989;170:35–40.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci. 1999;19:4011–4022.
   PubMed Web of Science ®Google Scholar
• Calamaro CJ, Mason TB, Ratcliffe SJ. Adolescents living the 24/7 lifestyle: effects of caffeine and technology on sleep duration and daytime functioning. Pediatrics. 2009;123:e1005–10.
   PubMed Web of Science ®Google Scholar
• Simola N, Cauli O, Morelli M. Sensitization to caffeine and cross-sensitization to amphetamine: influence of individual response to caffeine. Behav Brain Res. 2006;172:72–79.
   PubMed Web of Science ®Google Scholar
• Tronci E, Simola N, Carta AR, et al. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons. J Neurochem. 2006;98:1078–1089.
   PubMed Web of Science ®Google Scholar
• Hsu CW, Chen CY, Wang CS, et al. Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice. Psychopharmacology (Berl. 2009;204:313–325.
   PubMed Web of Science ®Google Scholar
• Celik E, Uzbay IT, Karakas S. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:50–55.
   PubMed Web of Science ®Google Scholar
• Kamimori GH, Karyekar CS, Otterstetter R, et al. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int J Pharm. 2002;234:159–167.
   PubMed Web of Science ®Google Scholar
• Syed SA, Kamimori GH, Kelly W, et al. Multiple dose pharmacokinetics of caffeine administered in chewing gum to normal healthy volunteers. Biopharm Drug Dispos. 2005;26:403–409.
   PubMed Web of Science ®Google Scholar
• Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6:67–74.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang X, Ge W, et al. The pharmacokinetics of inhaled morphine delivered by an ultrasonic nebulizer in ventilated dogs. J Aerosol Med Pulm Drug Deliv. 2012;25:41–46.
   PubMed Web of Science ®Google Scholar
• Ueno H, Suemitsu S, Murakami S, et al. Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice. Biomed Pharmacother. 2019;117:109038.
   PubMed Web of Science ®Google Scholar
• Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci. 2004;61:857–872.
   PubMed Web of Science ®Google Scholar
• El Yacoubi M, Ledent C, Ménard JF, et al. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol. 2000;129:1465–1473.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Le Moine C, Kull B, et al. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience. 1997;80:1171–1185.
   PubMed Web of Science ®Google Scholar
• Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001;24:31–55.
   PubMed Web of Science ®Google Scholar
• Cunha RA. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int. 2001;38:107–125.
   PubMed Web of Science ®Google Scholar
• Sebastião AM, Ribeiro JA. Adenosine receptors and the central nervous system. Handb Exp Pharmacol. 2009;193:471–534.
   Google Scholar
• Schiffmann SN, Libert F, Vassart G, et al. Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett. 1991;130:177–181.
   PubMed Web of Science ®Google Scholar
• Fredholm BB, IJzerman AP, Jacobson KA, et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 2001;53:527–552.
   PubMed Web of Science ®Google Scholar
• Galvalisi M, Prieto JP, Martínez M, et al. Caffeine Induces a Stimulant Effect and Increases Dopamine Release in the Nucleus Accumbens Shell Through the Pulmonary Inhalation Route of Administration in Rats. Neurotox Res. 2017;31:90–98.
   PubMed Web of Science ®Google Scholar
• Kaplan GB, Greenblatt DJ, Ehrenberg BL, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997;37:693–703.
   PubMed Web of Science ®Google Scholar
• Garrett BE, Holtzman SG. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol Biochem Behav. 1994;47:89–94.
   PubMed Web of Science ®Google Scholar
• Halldner L, Adén U, Dahlberg V, et al. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors. Neuropharmacology. 2004;46:1008–1017.
   PubMed Web of Science ®Google Scholar
• Abreu RV, Silva-Oliveira EM, Moraes MFD, et al. Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains. Pharmacol Biochem Behav. 2011;99:659–664.,
   PubMed Web of Science ®Google Scholar
• Kaidanovich-Beilin O, Lipina T, Vukobradovic I, et al. Assessment of social interaction behaviors. J Vis Exp. 2011;25:48.
   Google Scholar
• Ferre S, Ciruela F, Borycz J, et al. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci. 2008;13:2391–2399.
   Google Scholar
• Ferré S. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J Alzheimers Dis. 2010;20 Suppl 1:S35–49.
   Google Scholar
• Mumford GK, Holtzman SG. Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther. 1991;258:857–865.
   PubMed Web of Science ®Google Scholar
• Malec D, Poleszak E. Involvement of adenosine receptors in dizocilpine-induced motor activity in mice. Pharmacol Rep. 2006;58:101–106.
   PubMed Web of Science ®Google Scholar
• Uchiyama H, Toda A, Imoto M, et al. The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice. Neurosci Lett. 2010;469:184–188.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yu YP, Ye YL, et al. Spatiotemporal properties of locomotor activity after administration of central nervous stimulants and sedatives in mice. Pharmacol Biochem Behav. 2011;97:577–585.
   PubMed Web of Science ®Google Scholar
• Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science. 1987;238:797–799.
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Nomikos GG, Ongini E, et al. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience. 1997;79:753–764.
   PubMed Web of Science ®Google Scholar
• Polese G, Winlow W, Di Cosmo A. Dose-dependent effects of the clinical anesthetic isoflurane on Octopus vulgaris: a contribution to cephalopod welfare. J Aquat Anim Health. 2014;26:285–294.
   PubMed Web of Science ®Google Scholar
• Zhou J, Iwasaki S, Yamakage M. Time- and Dose-Dependent Effects of Desflurane in Sensitized Airways. Anesth Analg. 2017;124:465–471.
   PubMed Web of Science ®Google Scholar
• Crowe TP, Greenlee MHW, Kanthasamy AG, et al. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018;195:44–52.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Pronk GJ, Padmanabhan V, et al. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127:481–496. 2nd.
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WH. 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99:1654–1673.
   PubMed Web of Science ®Google Scholar
• Bitter C, Suter-Zimmermann K, Surber C. Nasal drug delivery in humans. Curr Probl Dermatol. 2011;40:20–35.
   PubMedGoogle Scholar
• Jogani V, Jinturkar K, Vyas T, et al. Recent patents review on intranasal administration for CNS drug delivery. DDF. 2008;2:25–40.
   Google Scholar
• De Pauw K, Roelands B, Van Cutsem J, et al. Do glucose and caffeine nasal sprays influence exercise or cognitive performance? Int J Sports Physiol Perform. 2017;12:1186–1191.
   PubMed Web of Science ®Google Scholar
• De Pauw K, Roelands B, Van Cutsem J, et al. Electro-physiological changes in the brain induced by caffeine or glucose nasal spray. Psychopharmacology (Berl). 2017;234:53–62.
   PubMed Web of Science ®Google Scholar
• Wickham KA, Spriet LL. Administration of caffeine in alternate forms. Sports Med. 2018;48:79–91.
   PubMed Web of Science ®Google Scholar